Negative sentiment towards TWST reflected in surge in short interest

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Twist Bioscience Corp shares valued at $79,773 were purchased by Finn Patrick John on Jul 23 ’25. At $35.74 per share, Finn Patrick John acquired 2,232 shares.

Also, Laponis Adam sold 2,449 shares, netting a total of over 93,420 in proceeds. Following the sale of shares at $38.15 each, the insider now holds 103,569 shares.

Before that, Laponis Adam had added 2,449 shares to its account. In a trade valued at $93,419, the Officer bought Twist Bioscience Corp shares for $38.15 each.

As published in their initiating research note from Wolfe Research on December 13, 2024, Twist Bioscience Corp [TWST] has been an Outperform and the price target has been revised to $60. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of January 17, 2024, Goldman has increased its “Neutral” rating to a “Buy” for TWST. Earlier on September 27, 2023, Berenberg initiated its rating. Their recommendation was “a Buy” for TWST stock.

Analyzing TWST Stock Performance

On last trading session,, Twist Bioscience Corp [NASDAQ: TWST] plunged -2.64% to $35.08. The stock’s lowest price that day was $34.98, but it reached a high of $35.99 in the same session. During the last five days, there has been a drop of approximately -2.15%. Over the course of the year, Twist Bioscience Corp shares have dropped approximately -37.60%. Shares of the company reached a 52-week high of $55.33 on 01/24/25 and a 52-week low of $27.12 on 05/23/25.

Support And Resistance Levels for Twist Bioscience Corp (TWST)

According to the 24-hour chart, there is a support level at 34.70, which, if violated, would cause prices to drop to 34.31. In the upper region, resistance lies at 35.73. The next price resistance is at 36.37. RSI (Relative Strength Index) is 46.70 on the 14-day chart, showing neutral technical sentiment.

Is Twist Bioscience Corp subject to short interest?

Stocks of Twist Bioscience Corp saw a sharp rise in short interest on 2025-06-30 jumping by 0.35 million shares to 11.03 million. Data from Yahoo Finance shows that the short interest on 2025-05-30 was 10.68 million shares. A jump of 3.18% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.56 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.56.

Which companies own the most shares of Twist Bioscience Corp (TWST)?

In terms of Twist Bioscience Corp share price expectations, FactSet research, analysts set an average price target of 50 in the next 12 months, up nearly 38.77% from the previous closing price of $36.03. Analysts anticipate Twist Bioscience Corp stock to reach 58 by 2025, with the lowest price target being 44. In spite of this, 7 analysts ranked Twist Bioscience Corp stock as Buy at the end of 2025. On January 05, 2023, Scotiabank assigned a price target of “a Sector outperform” to the stock and initiated coverage with a $33.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.